{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:28:33Z","timestamp":1761236913244},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,11,1]]},"DOI":"10.1038\/sj.bmt.1703245","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T16:39:28Z","timestamp":1032280768000},"page":"821-825","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of existing limited sampling models for busulfan kinetics in children with beta thalassaemia major undergoing bone marrow transplantation"],"prefix":"10.1038","volume":"28","author":[{"given":"P","family":"Balasubramanian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Chandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,11,26]]},"reference":[{"key":"BF1703245_CR1","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","volume":"309","author":"GW Santos","year":"1983","unstructured":"Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute non-lymphocytic leukaemia after treatment with busulfan and cyclophosphamide New Engl J Med 1983 309: 1347\u20131353","journal-title":"New Engl J Med"},{"key":"BF1703245_CR2","first-page":"201","volume":"1","author":"JR Hobbs","year":"1986","unstructured":"Hobbs JR, Hugh Jones K, Shaw PJ et al. Engraftment rates related to busulfan\/cyclophosphamide dosages for displacement marrow transplantation in 50 children Bone Marrow Transplant 1986 1: 201\u2013208","journal-title":"Bone Marrow Transplant"},{"key":"BF1703245_CR3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","volume":"322","author":"G Lucarelli","year":"1990","unstructured":"Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in patients with thalassemia New Engl J Med 1990 322: 417\u2013421","journal-title":"New Engl J Med"},{"key":"BF1703245_CR4","first-page":"31","volume":"16","author":"JT Slattery","year":"1995","unstructured":"Slattery JT, Sanders JE, Buckner CD et al. Graft rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics Bone Marrow Transplant 1995 16: 31\u201342","journal-title":"Bone Marrow Transplant"},{"key":"BF1703245_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00694339","volume":"25","author":"LB Grochow","year":"1989","unstructured":"Grochow LB, Jones RJ, Brundrett RB et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation Cancer Chemother Pharmacol 1989 25: 55\u201361","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1703245_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/clpt.1993.108","volume":"54","author":"MB Regazzi","year":"1993","unstructured":"Regazzi MB, Locatelli F, Buggia I et al. Disposition of high dose busulfan in pediatric patients undergoing bone marrow transplantation Clin Pharmacol Ther 1993 54: 45\u201352","journal-title":"Clin Pharmacol Ther"},{"key":"BF1703245_CR7","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V82.3.1030.1030","volume":"82","author":"G Vassal","year":"1993","unstructured":"Vassal G, Fischer A, Challine D et al. Busulfan disposition below the age of three: alteration in children with lysosomal storage disease Blood 1993 82: 1030\u20131034","journal-title":"Blood"},{"key":"BF1703245_CR8","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1182\/blood.V93.12.4436","volume":"93","author":"JP Gibbs","year":"1999","unstructured":"Gibbs JP, Gooley T, Corneau B et al. The impact of obesity and disease on busulfan oral clearance in adults Blood 1999 93: 4436\u20134440","journal-title":"Blood"},{"key":"BF1703245_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/BF00689702","volume":"28","author":"M Hassan","year":"1989","unstructured":"Hassan M, Oberg G, Bekassy AN et al. Pharmacokinetics of high dose busulfan in relation to age and chronopharmacology Cancer Chemother Pharmacol 1989 28: 130\u2013134","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1703245_CR10","first-page":"1534","volume":"53","author":"G Vassal","year":"1993","unstructured":"Vassal G, Challine D, Koscielny S et al. Chronopharmacology of high dose busulfan in children Cancer Res 1993 53: 1534\u20131537","journal-title":"Cancer Res"},{"key":"BF1703245_CR11","first-page":"759","volume":"14","author":"U Schuler","year":"1994","unstructured":"Schuler U, Schroer S, Kuhnle A et al. Busulfan pharmacokinetics in bone marrow transplant patients: is therapeutic drug monitoring warranted? Bone Marrow Transplant 1994 14: 759\u2013765","journal-title":"Bone Marrow Transplant"},{"key":"BF1703245_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF00686213","volume":"33","author":"M Hassan","year":"1993","unstructured":"Hassan M, Oberg G, Bjorkholm M et al. Influence of prophylactic anticonvulsant therapy on high dose busulfan kinetics Cancer Chemother Pharmacol 1993 33: 181\u2013186","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1703245_CR13","first-page":"225","volume":"17","author":"SP Dix","year":"1996","unstructured":"Dix SP, Wingard JR, Mullins RE et al. Association of busulfan area under the curve with veno-occlusive disease following BMT Bone Marrow Transplant 1996 17: 225\u2013230","journal-title":"Bone Marrow Transplant"},{"key":"BF1703245_CR14","first-page":"341","volume":"17","author":"T Demirer","year":"1996","unstructured":"Demirer T, Buckner CD, Appelbaum FR et al. Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukaemia: phase I dose escalation of busulfan based on targeted plasma levels Bone Marrow Transplant 1996 17: 341\u2013346","journal-title":"Bone Marrow Transplant"},{"key":"BF1703245_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0950-3536(98)80073-5","volume":"11","author":"N Olivieri","year":"1998","unstructured":"Olivieri N . Thalassaemia: clinical management Bailli\u00e8res Clin Haematol 1998 11: 147\u2013162","journal-title":"Bailli\u00e8res Clin Haematol"},{"key":"BF1703245_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2141.1999.01680.x","volume":"107","author":"P Richardson","year":"1999","unstructured":"Richardson P, Guinan E . The pathology, diagnosis and treatment of hepatic veno-occlusive disease: current status and novel approaches Br J Haematol 1999 107: 485\u2013493","journal-title":"Br J Haematol"},{"key":"BF1703245_CR17","first-page":"127a","volume":"92","author":"D Dennison","year":"1998","unstructured":"Dennison D, Chandy M, Poonkuzhali B et al. Plasma busulfan levels influence rejection in bone marrow transplantation for homozygous beta thalassaemia Blood 1998 92: 127a","journal-title":"Blood"},{"key":"BF1703245_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/sj.bmt.1701814","volume":"24","author":"B Poonkuzhali","year":"1999","unstructured":"Poonkuzhali B, Srivastava A, Quernin MH et al. Pharmacokinetics of oral busulfan in children with thalassemia undergoing BMT Bone Marrow Transplant 1999 24: 5\u201311","journal-title":"Bone Marrow Transplant"},{"key":"BF1703245_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0378-4347(98)00473-3","volume":"721","author":"MH Quernin","year":"1999","unstructured":"Quernin MH, Poonkuzhali B, Medard Y et al. High performance liquid chromatographic method for quantification of busulfan in plasma after derivatization by tetrafluorothiophenol J Chromatogr 1999 721: 147\u2013152","journal-title":"J Chromatogr"},{"key":"BF1703245_CR20","volume-title":"Pharmacokinetic pharmacodynamic data analysis system for the PC","author":"G Heinzel","year":"1993","unstructured":"Heinzel G, Woloszezak R, Thoman P . Pharmacokinetic pharmacodynamic data analysis system for the PC Gustav Fischer: Stuttgart, Germany 1993"},{"key":"BF1703245_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.bmt.1700891","volume":"20","author":"DS Chattergoon","year":"1997","unstructured":"Chattergoon DS, Saunders EF, Klein J et al. An improved limited sampling method for individualized busulfan dosing in bone marrow transplantation in children Bone Marrow Transplant 1997 20: 347\u2013354","journal-title":"Bone Marrow Transplant"},{"key":"BF1703245_CR22","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood.V79.9.2475.2475","volume":"79","author":"G Vassal","year":"1992","unstructured":"Vassal G, Deroussent A, Challine D et al. Is 600\u2009mg\/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood 1992 79: 2475\u20132479","journal-title":"Blood"},{"key":"BF1703245_CR23","first-page":"843","volume":"18","author":"M Hassan","year":"1996","unstructured":"Hassan M, Fasth A, Gerritsen B et al. Busulfan kinetics and limited sampling model in children with leukaemia and inherited disorders Bone Marrow Transplant 1996 18: 843\u2013850","journal-title":"Bone Marrow Transplant"},{"key":"BF1703245_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0010-468X(79)90025-4","volume":"9","author":"DZ D'Argenio","year":"1979","unstructured":"D'Argenio DZ, Schumitzky A . A program package for simulation and parameter estimation in pharmacokinetic systems Comp Prog Biomed 1979 9: 115\u2013134","journal-title":"Comp Prog Biomed"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703245","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:25:43Z","timestamp":1648074343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,11,1]]}},"alternative-id":["BF1703245"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703245","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11,1]]},"assertion":[{"value":"22 June 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}